Search Results

The EyeQ nanoECP System is indicated for intraoperative photocoagulation of the ciliary processes in the treatment of glaucoma, and for evaluation of the internal ocular structures in patients with dense opacifications of the anterior segment which do not allow a posterior view. Glaucoma - This instrument is indicated for the treatment of glaucoma in patients who have failed with conventional topical and systemic medications, or previous laser photocoagulation, or trabeculectomy and other filtering procedures, or cyclocryotherapy or other cyclodestructive procedures.

Not Found

The Leos system is indicated for intraoperative photocoagulation of the ciliary processes in the treatment of glaucoma, proliferative retinopathies, retinal detachment, and for evaluation of the internal ocular structures in patients with dense opacifications of the anterior segment which do not allow a posterior view. **Glaucoma** - This instrument is indicated for the treatment of glaucoma in patients who have failed with conventional topical and systemic medications, or previous laser photocoagulation, or trabeculectomy and other filtering procedures, or cyclocryotherapy or other cyclodestructive procedures. **Vitreoretinal Surgery** - The endoscopically controlled endophotocoagulation that is possible with the ophthalmic laser endoscope is also useful for endophotocoagulation: - During vitreous surgery to produce chorioretinal scar around retinal breaks or retinotomy sites. - To perform intraoperative panretinal photocoagulation (PRP) in proliferative retinopathies. - To perform intraoperative retinal photocoagulation on a scleral buckle. - To perform intraoperative photocoagulation around focal neovascularization

The Leos Laser and Endoscopic System is a next generation ophthalmic laser and endoscopy system used for the treatment of glaucoma, vitreoretinal diseases, and intraocular visualization. The system contains an 810 nm powered diode laser delivered by the stainless-steel endoscopic laser probe (trade name: VueProbe), which is placed into eye tissue to illuminate and visualize the target tissue and deliver laser energy under direct visualization. The console is a fully integrated portable device, containing a laser module assembly, viewing and control monitors, and a wireless footswitch for activating the laser. The larger passive monitor is for viewing the endoscopic video image and key treatment information, while the smaller touchscreen is used for parameters selection, rotation and viewing. The camera chip uses CMOS technology and is located at the tip of the probe. The LED light source is located within the plastic handpiece of the probe and illumination fibers carry the light to the tip. Additionally, the probe contains a laser fiber within its full length.

The Norlase LYNX Photocoagulator is intended to be used in ophthalmic laser procedures including retinal and macular photocoagulation, iridotomy, and trabeculoplasty.

Not Found

VISULAS combi is intended for use in photocoagulating and photodisrupting ocular tissues in the treatment of diseases of the eye, including: • Photocoagulation of the retina - Trabeculoplasty - · Iridotomy - · Posterior capsulotomy · Posterior membranectomy This device is Prescription Use (Rx) only.

VISULAS combi is an ophthalmic laser used for standard photocoagulation treatments of ocular tissue with 532 nm wavelength and standard photodisruption treatments of ocular tissues at a wavelength of 1064 mm. VISULAS combi is operated in the following treatment modes: - single-spot mode (software license VERTE) - - multi-spot mode (software license VITE) - YAG disruption mode (software license YAG). - VISULAS combi consists of a laser console, touch control panel, optional laser light applicators such as laser slit lamp or laser indirect ophthalmoscope, foot switch and instrument table. The device can also be used with various accessories, such as SL Imaging Solution, contact lenses or Applanation Tonometer.

The MR Q and the MR SUPINE are intended to perform: - Posterior capsulotomy - - Iridotomy - The MR Q SLT in YAG mode is intended to perform: - Posterior capsulotomy - - -Iridotomy The MR Q SLT in SLT mode is intended to perform: - Selective laser trabeculoplasty

Not Found

The Eagle device is indicated for use in selective laser trabeculoplasty (SLT).

The Eagle device is a Q-switched, 532 nm-wavelength, frequency-doubled Nd:YAG laser that is intended for use in performing selective laser trabeculoplasty. The laser spots produced by the Eagle device have a 400 um spot size, a 3 ns pulse duration, and a 50-Hz pulse repetition rate. The sequence of laser spots consists of 120 spots in a predefined circumferential elliptical pattern delivered at a pre-defined pulse energy level. The spots are delivered through the limbus to the trabecular meshwork in a non-contact fashion, without the need for the use of a contact gonioscopy lens. The device automatically locates the treatment location. The treatment location may be adjusted slightly by the operator. Once confirmed by the operator, the device then automatically applies the laser treatment sequence to the limbal region of the eye, while the eye tracker compensates for any eye movement. The default energy setting is 1.8 mJ/pulse.

VISULAS green is intended for use in photocoagulating ocular tissues of the treatment of diseases of the eve, including - · Photocoagulation of the retina - Trabeculoplasty - · Iridotomy

VISULAS green is an ophthalmic laser used for standard photocoagulation treatments of ocular tissue with 532 nm wavelength. VISULAS green is operated in single-spot mode or in multi-spot mode. VISULAS green consists of a laser console, touch control panel, optional laser light applicators such as laser slit lamp or laser indirect ophthalmoscope, foot switch and instrument table. The device can also be used with various accessories, such as SL Imaging Solution, contact lenses or Applanation Tonometer.

VISULAS yag is intended for use in photodisrupting ocular tissue in the treatment of diseases of the eye, including Posterior capsulotomy, Iridotomy and Posterior Membranectomy. This device is for Prescription Use (Rx) only.

VISULAS yag uses a Q-switched, flashlamp-pumped solid-state laser for photodisruption treatments of diseases of the eye, including posterior capsulotomy, iridotomy and membranectomy. Laser radiation is generated by means of a neodymium-doped yttrium aluminum garnet (Nd:YAG) gain medium inside the laser source. The emitted laser radiation with a near-infrared wavelength of = 1064 nm has a pulse duration of < 4 ns (full-width half-maximum; FWHM) and a focal diameter of 6.5 um ± 20%. The maximum energy output per pulse is 9 to 13 mJ in single-burst mode.

The MERILAS 810 shortpulse laser is indicated for: - Photocoagulation - Iridotomy - Trabeculoplasty - Thermotherapy The MERILAS 532 shortpulse laser is indicated for: - Photocoagulation - Iridotomv - Trabeculoplasty The MERILAS 577 shortpulse laser is indicated for: - Photocoagulation - Iridotomy - Trabeculoplasty

Not Found

The Iridex® Laser Console (532 model) are solid state lasers that are used to deliver laser energy in either continuous wave pulse (CW-pulse® mode, for ophthalmic applications (532 and 577 models) and for Ear, Nose, and Throat (Otolaryngology) applications (532 model only). Iridex® 532 Laser The Iridex® 532 Laser is indicated for use in soft and fibrous tissue, including osseous tissue incision, excision, coagulation, vaporization, ablation and vessel hemostasis in the medical specialties of, ear, nose and throat (ENT)/otolaryngology, and ophthalmology as follows: Ophthalmology Indicated for retinal photocoagulation, laser trabeculoplasty, iridoplasty including: - · Retinal photocoagulation (RPC) for the treatment of - o Diabetic retinopathy, including: - Nonproliferative retinopathy - Macular edema - Proliferative retinopathy - o Retinal tears and detachments - o Lattice degeneration - o Age-related macular degeneration (AMD) - o Retinopathy of prematurity - o Sub-retinal (choroidal) neovascularization - o Central and branch retinal vein occlusion - · Laser trabeculoplasty, iridotomy, iridoplasty for the treatment of glaucoma, including - o Primary open angle/Closed angle Ear, Nose, and Throat (ENT)/Otolaryngology Otosclerotic Hearing loss and/or diseases of the inner ear: - · Stapedectomy - · Stapedotomy - · Myringotomies - · Lysis of Adhesions - · Control of Bleeding - · Removal of Acoustic Neuromas - · Soft tissue Adhesion in Micro/Macro Otologic Procedures Iridex® 577 Laser The Iridex® 577 Laser is indicated for use in soft and fibrous tissue, including osseous tissue incision, excision, coagulation, vaporization, ablation and vessel hemostasis in the medical specialty of ophthalmology as follows: Ophthalmology Indicated for use in photocoagulation of both anterior and posterior segments including: - · Retinal photocoagulation, panretinal photocoagulation and intravitreal endophotocoagulation of vascular and structural abnormalities of the retina and choroid including: o Proliferative and nonproliferative diabetic retinopathy o Choroidal neovascularization o Branch retinal vein occlusion o Age-related macular degeneration (AMD) o Retinal tears and detachments o Retinopathy of prematurity · Iridotomy, iridectomy and trabeculoplasty in angle closure glaucoma and open angle glaucoma

The Iridex 532/577 Laser consoles are solid state lasers that are used to deliver laser energy in continuous wave and MicroPulse® for ophthalmic applications and (for 532 only) ear, nose, and throat (ENT) / otolaryngology applications. The Iridex® 532 Laser delivers a 532 nm wavelength (green) laser emission, and the Iridex® 577 Laser delivers a 577mm wavelength (true-yellow) laser emission. The Iridex 532 Laser and the Iridex 577 Laser systems are comprised of a laser console with footswitch and an optical fiber delivery device. Each laser console model contains two laser diodes as follows: - Iridex 532 Laser: 532 nm for Treatment and 650 nm for Aiming beam ● - Iridex 577 Laser: 577 nm for Treatment and 650 nm for Aiming beam ● imaging optics, power supply, control electronics, and software/embedded firmware (with microprocessor). Lasing can only be initiated from the footswitch. Optical fiber Delivery Devices are provided separately.